QT Regulatory Thursday, November 12, 2026 +0.80 Positive

QT Breast Scanner deemed substantially equivalent by FDA

The U.S. Food and Drug Administration determined QT Imaging's QT Breast Scanner is substantially equivalent to a predicate device under the Food, Drug and Cosmetic Act, qualifying the device for marketing.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed